UPLOAD Filing
OS Therapies Inc
Date: Aug. 13, 2025 · CIK: 0001795091 · Accession: 0000000000-25-008544
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289443
Letter
Re: OS Therapies Incorporated Registration Statement on Form S-3 Filed August 8, 2025 File No. 333-289443 Dear Paul A. Romness:
August 13, 2025
Paul A. Romness Chief Executive Officer OS Therapies Incorporated 115 Pullman Crossing Road, Suite #103 Grasonville, MD21638
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Dakota J. Forsyth, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 13, 2025 Paul A. Romness Chief Executive Officer OS Therapies Incorporated 115 Pullman Crossing Road, Suite #103 Grasonville, MD21638 Re: OS Therapies Incorporated Registration Statement on Form S-3 Filed August 8, 2025 File No. 333-289443 Dear Paul A. Romness: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Dakota J. Forsyth, Esq. </TEXT> </DOCUMENT>